Skip to content
Palanor is in early release, with our founding customers.Become a founding customer →
PalanorPalanor

Line

HIV Treatment Coverage by Region

People living with HIV who receive antiretroviral therapy, World Bank regions, yearly, %

Sub-Saharan Africa: 83% in 2024+6 pp since 2022

4 of 4 series are above their level a year earlier

Plays the chart through its history. Pauses are where the data set a record or moved most.

Palanor Foresight™ comes with a free Palanor account. Create one · Continuation is open to everyone.

World Bank WDI (CC BY 4.0), compiled from UNAIDS estimates. The denominator is everyone estimated to be living with HIV, diagnosed or not. World Bank regions; regions without a published estimate are left out.

The share of people with HIV who are on treatment. Almost no one in Sub-Saharan Africa was treated at the turn of the century; the region is now ahead of the world average. The Middle East and North Africa lag far behind.

What this chart reads

Sources

Sub-Saharan Africa · HIV Treatment Coverage · % of people living with HIV. Source: World Bank WDI (CC BY 4.0), compiled from UNAIDS estimates. Indicator SH.HIV.ARTC.ZS. Palanor reads it each month and rewrites the history, so revisions carry through.

Latin America & Caribbean · HIV Treatment Coverage · % of people living with HIV. Source: World Bank WDI (CC BY 4.0), compiled from UNAIDS estimates. Indicator SH.HIV.ARTC.ZS. Palanor reads it each month and rewrites the history, so revisions carry through.

Middle East, North Africa, Afghanistan & Pakistan · HIV Treatment Coverage · % of people living with HIV. Source: World Bank WDI (CC BY 4.0), compiled from UNAIDS estimates. Indicator SH.HIV.ARTC.ZS. Palanor reads it each month and rewrites the history, so revisions carry through.

World · HIV Treatment Coverage · % of people living with HIV. Source: World Bank WDI (CC BY 4.0), compiled from UNAIDS estimates. Indicator SH.HIV.ARTC.ZS. Palanor reads it each month and rewrites the history, so revisions carry through.

Charts are drawn from Palanor's signal library and recomputed from source data on every view. Transformations (changes, indexing, year-on-year rates) are Palanor's.

Related charts

HealthForecast

Drug Stocks Against the Market

Twenty large U.S.-listed drugmakers (by market value) and the S&P 500, price indexed to the start of the window

197.2Data yesterday
HealthForecast

U.S. Uninsured Rate

Share of people in the United States with no health insurance, annual, %

8.2%Data to Dec 2024
HealthForecast

U.S. Drug Overdose Deaths

Drug overdose deaths in the U.S., 12 months ending each month

66,478Data to May 2026
HealthForecast

FDA Novel Drug Approvals

New drugs approved by the FDA’s drug center, trailing 12 months

59Data 51 days ago
Health· StudioForecast

FDA Novel Drug Approvals, Trailing 12 Months

New molecular entities and new therapeutic biologics approved by FDA's Center for Drug Evaluation and Research.

59.0Data 51 days ago
HealthForecast

Donor Aid for Health

Bilateral aid disbursements from DAC member countries by sector, US$ billions, current prices, yearly

$7.3B1 viewsData to Dec 2024

Cookies

We only use essential cookies to keep you signed in and remember your theme. No analytics, no tracking, no ads. See the Privacy Policy for the full read.